High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen

Leukemia and Lymphoma

Volumn 29, Issue 1-2, 1998, Pages 171-177

  Ogawa, Hiroyasu ^a   Sugiyama, Haruo ^a   Tani, Yoshihiko ^a   Soma, Toshihiro ^a   Yamagami, Tamotsu ^a   Tatekawa, Toyoshi ^a   Oji, Yusuke ^a   Kubota, Takeshi ^a   Kimura, Takafumi ^a   Inoue, Kazushi ^a   Nakagawa, Masashi ^a   Sasaki, Koichi ^a   Matsunashi, Tatsuro ^a   Miyake, Seigou ^a   Kishimoto, Tadamitsu ^a  

^a NONE

Author keywords

Chemotherapy induced acral erythema; Granulocyte colony stimulating factor; Non Hodgkin's lymphoma; VACOP B regimen

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; SEX HORMONE; VINCRISTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ERYTHEMA; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEX RATIO;

EID: 7144242342     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058392     Document Type: Article

References (23)

1. Baock, B. R. and Burgdorf, W. H. C. (1991). Chemotherapy-induced acral erythema. Journal of American Academy of Dermatology, 24, 457-461.
2. Crider, M. K., Jansen, J., Norins, A. L. and McHale, M. S. (1986). Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation. Archives of Dermatology, 122, 1023-1027.
3. Kampmann, K. K., Graves, T. and Rogers, S. D. (1989). Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporin infusion. Cancer, 63, 2482-2485.
4. Reynaert, H., Coninck, A. D., Neven, A. M., Camp, B. V. and Schots, R. (1992). Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 10, 185-187.
5. Silver, F. S., Espinoza, L. R. and Harmann, R. C. (1983). Acral erythema and hydroxyurea. Annals of Internal Medicine, 98, 675.
6. Lokich, J. J. and Moore, C. (1984). Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine, 101, 798-800.
7. Doyle, L. A., Berg, C., Bottino, G. and Chabner, B. (1983). Erythema and desquamation after high-dose methotrexate. Annals of Internal Medicine, 98, 611-612.
8. Cox, G. J. and Robertson, D. B. (1986). Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Archives of Dermatology, 122, 1413-1414.
9. Zuehlke, R. L. (1974). Erythematous eruption of the palms and soles associated with mitotane therapy. Dermatologica, 148, 90-92.
10. Baer, M. R., King, L. E. and Wolff, S. N. (1985). Palmar-Plantar erythrodysesthesia and cytarahine. Annals of Internal Medicine, 102, 556.
11. Levine, L. E., Medenica, M. M. and Lorinez, A. L. (1985). Distinctive acral erythema occurring during therapy for severe myelogenous leukemia. Archives of Dermatology, 121, 102-104.
12. Burgdorf, W. H. C., Gilmore, W. A. and Ganick, R. G. (1982). Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Annals of Internal Medicine, 97, 61-62.
13. O'Reilly, S. E., Hoskins, P., Klimo, P. and Connors, J. M. (1991). MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Annals of Oncology, 2 (Suppl. 1), 17-23.
14. Klimo, P. and Connors, J. M. (1985). MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Annals of Internal Medicine, 102, 596-602.
15. Coltman, C. A., Luce, J. K., McKelvey, E. M., Jones, S. E. and Moon, T. E. (1977). Chemotherapy of non-Hodgkin's lymphoma: 10 years experience in the Southwest Oncology Group. Cancer Treatment Report, 61, 1067-1078.
16. Oyama, A., Ota, K., Suchi, T., Kurita, S., Ariyoshi, Y., Murakami, M., et al. (1988). Chemotherapy for non-Hodgkin's lymphoma. intermediate grade and immunoblastic. In: Kimura, K. et al. Cancer Chemotherapy: Challenges for the Future, vol 3 (Excerpta Medica, Tokyo) pp. 208-215.
17. Portal, I., Cardenal, F. and Garcia-del-Muro, X. (1994). Etoposide-related acral erythema. Cancer Chemotherapy Pharmacology, 34, 181.
18. Bellmunt, J., Navarro, M., Morales, S., Jolis, L., Carulla, J., Knobell, H., et al. (1990). Capillary microscopy is a potentially useful method for detecting bleomycin vascular toxicity. Cancer, 65, 303-309.
19. Cohen, I. S., Mosher, M. B., O'Keefe, E. J., Klaus, S. N. and De Conti, R. C. (1973). Cutaneous toxicity of bleomycin therapy. Archives of Dermatology, 107, 553-555.
20. Cohen, P. R. (1993). Acral erythema: a clinical review. Cutis, 51, 175-179.
21. Peter, W. G. and Willemze, R. (1985). Palmar-plantar skin changes and cytarabine. Annals of Internal Medicine, 103, 805.
22. Horn, T. D., Beveridge, R. A., Egorin, M. J., Abeloff, M. D. and Hood, A. F. (1989). Observations and proposed mechanism of N, N′, N″-triethylene-thiophosphoramide (thiotepa)-induced hyperpigmentation. Archives of Dermatology, 125, 524-527.
23. Fraser, D., Padwick, M. L., Whitehead, M., Coffer, A. and King, R. J. (1991). Presence of an oestradiol receptor-related protein in the skin changes during the normal menstrual cycle. British Journal of Obstetrics and Gynaecology, 98, 1277-1282.